[Congressional Record Volume 162, Number 33 (Tuesday, March 1, 2016)]
[Senate]
[Page S1167]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3384. Mr. MARKEY submitted an amendment intended to be proposed by 
him to the bill S. 524, to authorize the Attorney General to award 
grants to address the national epidemics of prescription opioid abuse 
and heroin use; which was ordered to lie on the table; as follows:

       At the end, add the following:

     SEC. 705. ADVISORY COMMITTEE FOR APPROVAL OF NEW OPIOID 
                   DRUGS.

       Section 505 of the Federal Food, Drug, and Cosmetic Act (21 
     U.S.C. 355) is amended by adding at the end the following:
       ``(y) Advisory Committee Regarding Opioid Drugs.--
     Notwithstanding any other provision of this Act, the 
     Secretary shall convene a panel of experts, which shall 
     expressly consider the issues of addiction, abuse, and 
     dependence--
       ``(1) to review an application submitted under subsection 
     (b) or (j) for a new drug that is an opioid before the 
     Secretary may approve such application; and
       ``(2) to review a supplement to an application approved 
     under this section for a drug that is an opioid before the 
     Secretary may approve such supplement.''.
                                 ______